Efficacy within reach
Is affordability a pipe dream?
article
Complexities in forecasting eligible cases and associated costs of cell and gene therapy
Read the articleWHITE PAPER
Payer strategies for GLP-1 medications for weight loss
We examine various strategies related to GLP-1 medications such as Wegovy when used for weight loss to help payers understand the landscape, develop a coverage strategy, and minimize waste.
Article
NADAC-plus: An emerging paradigm in pharmacy pricing
LWith increased consumer and regulatory scrutiny on drug prices, stakeholders in the pharmacy supply chain are exploring drug pricing alternatives.
Article
Medicare Part D risk and claim cost changes with the Inflation Reduction Act
The Medicare Part D program is on the verge of massive change due to passage of the Inflation Reduction Act.
Products
Related Milliman products
Pharmaceutical claims analytics
MyRxConsultant
ACA compliance & affordability
Healthcare Reform Dashboard
Healthcare analytics
MedInsight
Services